HOUSTON--Lark Technologies has finalized an agreement with Pfizer to establish an in-house contract service laboratory focused on providing high-quality, fast-turnaround DNA sequencing services for Pfizer. Lark will provide the services in a laboratory exclusively dedicated to meeting the DNA sequencing requests of Pfizer at its UK facility in Sandwich.
Lark will work on behalf of Pfizer for specified fees on a no-rights-retained, contract basis. Lark said the deal is attractive for companies like Pfizer that have multiple project needs and require a consistent and reliable flow of high-quality DNA sequence information.